References
- Kaviratna A , BanerjeeR. Nanovesicle surfactants as aerosol therapy in lung injury. Nanomedicine (2012) (In Press).
- Beck-Broichsitter M , RuppertC, SchmehlTet al. Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro. Nanomedicine 7, 341–350 (2011).
- Choi HS , AshitateY, LeeJHet al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 28(12), 1300–1304 (2010).
- Ungaro F , d‘AngeloI, ColettaCet al. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. J. Control Release 157, 149–159 (2012).
- Al-Qadi S , GrenhaA, Carrión-RecioD, SeijoB, Remuñán-LópezC. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J. Control Release157, 383–390 (2012).
- Wong YL , SampsonS, GermishuizenWAet al. Drying a tuberculosis vaccine without freezing. Proc. Natl Acad. Sci. USA 104, 2591–2597 (2007).
- Boland S , GuadagniniR, Baeza-SquibanA, HussainS, MaranoF. Nanoparticles used in medical applications for the lung: hopes for nanomedicine and fears for nanotoxicity. J. Phys. Conf. Ser.304, 012031 (2011).
- Roller M . Carcinogenicity of inhaled nanoparticles. Inhal. Toxicol.21(Suppl. 1), 144–157 (2009).
- Card JW , ZeldinDC, BonnerJC, NestmannER. Pulmonary applications and toxicity of engineered nanoparticles. Am. J. Physiol. Lung Cell. Mol. Physiol.295, L400–L411 (2008).
- Yildirimer L , ThanhNTK, LoizidouM, SeifalianAM. Toxicological considerations of clinically applicable nanoparticles. Nano Today6, 585–607 (2011).